AFP and metabolic dysfunction-associated steatotic liver disease: NAFLD patients that are affected by HCC are mostly males, in their sixties, less frequently diagnosed during the surveillance protocols and with more advanced clinical stage and infiltrative tumor pattern, preserved liver function and low AFP serum level.